Business Wire

QD Laser, Inc.: Development of New Types of Retinal Scanning Laser Displays with Lower Cost and Smaller Size

Share

QD Laser, Inc. (Head office: Kawasaki City, Kanagawa Prefecture; President: Mitsuru Sugawara, hereinafter referred to as QD Laser) has succeeded in developing an innovative new retinal scanning laser displays by utilizing QD Laser’s proprietary retinal scanning projection technology. At the LASER World of PHOTONICS 2019 (Munich, Germany, June 24-27, 2019), two world premier prototypes will be exhibited and demoed.

  • Summary

QD Laser has succeeded in developing an innovative new retinal scanning laser eyewear by utilizing QD Laser’s proprietary retinal scanning projection technology. We have realized very inexpensive and miniaturized laser eyewear by combining our proprietary optical technology named VISIRIUM® technology with existing pico-projectors, At the LASER World of PHOTONICS 2019 (Munich, Germany, June 24-27, 2019), two prototypes will be exhibited and demoed.

  • Background

QD Laser has developed a laser retinal scanning technology named "VISIRIUM® Technology" that draws images directly onto the retina. This technology is based on the combination of laser and optical technology developed since its founding, combining weak light from a three-primary-color laser light source with a minute mirror (MEMS mirror) oscillating at high speed.
Launched in 2018, the "RETISSA® Display" is a head mounted display that is the first product of the commercialization of this "VISIRIUM® technology". Since its release, it has provided a new vision through Re-defining the Vision TM.
By diverting the existing pico-projector product and the pico-projector built-in smartphone as an image projection engine, the newly developed optical attachment enables safe and wide viewing angle retinal projection. By combining simple optics and commoditized projection devices, the devices offer lower cost, smaller size, and improved convenience.

  • Two prototypes to be unveiled this time
  1. Retissa Handy
    By combining a commercially available pico-projector with a unique Maxwell optics system, you can view a high-resolution retinal projection image in a hand-held size. The free focus feature allows you to enjoy an image with a horizontal viewing angle of 40 degrees naturally regardless of the focusing ability.
    As a new initiative, RETISSA® Handy has been used to train Uran Sawada, a member of the Japan Para Athletic Federation.

  2. Retissa Flex Periscope
    The combination of a small projector and an image-propagating optical system with a unique flexible structure enables a retinal projection display to be realized with the glasses in place without interfering with ordinary corrective glasses. The unique image propagation optics developed this time allows the size of parts around the eye to be minimized because there is no electrical circuit around the eyes. As with Retissa Handy above, the image quality does not depend on the user's vision due to the free focus feature. It is a technology that plays a role like an earphone in pico-projectors or smartphones with built-in pico-projectors.
  • Outlook

The superior portability and cost reduction features of the newly developed RETISSA® Handy and RETISSA® Flex Periscope make it easier for anyone to use a retinal scanning laser display. In the future, we plan to develop new features such as ultra-small and inexpensive perimeters, early detection of eye disease, self-examination of eye, peripheral vision training, and integration with smartphone applications and smartphone functions.
Starting from this exhibition, we will gather opinions and requests from various angles, and we will complete the products that are truly required by the market, in terms of cost, function, and design. In addition, we aim at wide spread of retinal scanning projection technology as application product of existing pico-projection, and we will seek business partners in various forms.

  • QD Laser, Inc.

QD Laser, Inc. was established as a spin-off venture from Fujitsu Ltd. (Head office: Minato-ku, Tokyo; President: Tatsuya Tanaka; hereinafter, Fujitsu) in April 2006, with the investment of Fujitsu and Mitsui & Co. Global Investment (former MVC) under Mitsui & Co., Ltd. (Head office: Chiyoda-ku, Tokyo; President: Tatsuo Yasunaga). Based on the joint development of Fujitsu Laboratories Ltd. (Head office: Kawasaki City, Kanagawa Prefecture, President: Hidenori Furuta) and the University of Tokyo by over 10 years of industry-academia collaboration, QD laser develops, manufactures and sells high-performance semiconductor lasers including quantum dot lasers from visible to 1300 nm in wavelength. The corporate statement “Through light, the world is evolving” symbolizes our will to contribute to society through laser and optical technologies.
We have continued development of for retinal scanning laser eyewear technology including a support for a clean device society implementation promotion project by the National Research and Development Corporation New Energy and Industrial Technology Development Organization (NEDO), and a support tool for practical application of welfare tool for FY2015. In 2018, we launched the world's first sales of RETISSA® Display, a consumer retina scanning laser eyewear.

  • RETISSA and VISIRIUM are registered trademarks of QD Laser, Inc. Other proper nouns such as listed product names are trademarks or registered trademarks of their respective owners.
  • There are individual differences in how to see.
  • Specifications are subject to change without notice.
  • This product is not a medical device. It is not intended to be used by people with visual impairment.

Contact information

Visual information division, QD Laser, Inc.
Nori MIYAUCHI
81-44-333-3338
email retissa@qdlaser.com
https://www.qdlaser.com/en/
https://www.qdlaser.com/en/applications/eyewear.html

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Aroma Bit to Develop Smartphone Embeddable Ultra-compact Silicon CMOS Based Smell Sensor That Has Dog Nose Equivalent Resolution in 1mm Squared Die Size23.7.2019 01:30:00 CESTPress release

Aroma Bit launched a new subsidiary to develop the next generation smell sensor based on silicon CMOS sensor substrate that are ultra-compact, high resolution and low cost. The technology is realized by applying Aroma Bit developed smell sensor receptor membrane technology to ultra-sensitive silicon CMOS based ion imaging sensor technology developed by professor Kazuaki Sawada at Toyohashi University of Technology and associated companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005004/en/ Picture of 1mm squared die of silicon CMOS based smell sensor, with dog nose equivalent ~1,200 sensor pixels (Photo: Business Wire) Aroma Bit: http://www.aromabit.com Realizing smartphone embeddable smell sensor with dog nose equivalent ultra-high resolution smell sensor on only 1 millimeter square silicon die size Aroma Bit has developed and are currently selling a compact smell sensor that employs QCM or Quartz Crystal Micro

Logitech Delivers a Strong Start to Fiscal Year 2020 with Robust Sales and Profit Growth23.7.2019 01:00:00 CESTPress release

Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005781/en/ Logitech delivers a strong start to Fiscal Year 2020 with robust sales and profit growth. (Graphic: Business Wire) Q1 sales were $644 million, up 6 percent in US dollars and 9 percent in constant currency, compared to Q1 of the prior year. Q1 GAAP operating income grew 46 percent to $47 million, compared to $32 million in the same quarter a year ago. Q1 GAAP earnings per share (EPS) grew 17 percent to $0.27, compared to $0.23 in the same quarter a year ago. Q1 non-GAAP operating income grew 11 percent to $67 million, compared to $61 million in the same quarter a year ago. Q1 non-GAAP EPS grew 15 percent to $0.39, compared to $0.34 in the same quarter a year ago. Cash flow from operations was $37 million, compared to $12 million in the sa

Gilead Presents New Data on Biktarvy® for the Treatment of HIV in Women and in Virologically Suppressed Patients With Known Resistance22.7.2019 16:00:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) today presented findings from two Phase 3 trials – a trial demonstrating the effectiveness of switching to Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets, B/F/TAF) in women, and a trial evaluating the potential for the single tablet regimen to be an effective treatment option in virologically suppressed patients with known resistance to nucleo(s)tide or non-nucleo(s)tide reverse transcriptase inhibitors (NRTIs or NNRTIs). The use of Biktarvy in patients with known drug resistance is investigational. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City. “These data presented at IAS provide new information about the treatment of HIV among women and patients with known drug resistance,” said Diana Brainard, MD, Senior Vice President, HIV and Emerging Viruses, Gilead Sciences. “The studies further demonstrate the potential for Biktarvy to be an

IBC Celebrates Young Talent in the Industry22.7.2019 15:36:00 CESTPress release

The media, entertainment and technology industry is changing. Attitudes are shifting, the next generation is consuming content differently to any before them and diverse and exciting content is being created to meet that demand in innovative formats. Driving this change is a new wave of industry talent, honoured at IBC with the first IBC Young Pioneer Award. Recognising the brightest, newest talent in the industry, this award will go to someone who has made a real impact with their passion, ambition and commitment and is making an outstanding contribution to our industry. “What we were looking for in the shortlist was, most importantly, real talent, a stand-out individual making a real difference in the industry,” said David Levine, VP, Programming - Kids, Europe & Africa/UK & Ireland, The Walt Disney Co. Ltd and Chair of the Judging Panel. “But we were also looking for a lasting legacy, for the Young Pioneer to be a leader today and a media guru of the future.” The call for entries so

Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV22.7.2019 15:00:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people living with HIV on GS-6207, an investigational, novel, selective, first-in-class inhibitor of HIV capsid function. The Phase 1b data demonstrate the first proof of concept that HIV capsid inhibition can lead to significant declines in viral load in vivo. In addition, Gilead presented preclinical data demonstrating that resistance to GS-6207 in vitro did not lead to resistance to other classes of drugs used in the treatment of HIV. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City. GS-6207 is an investigational long-acting antiretroviral agent that can be delivered subcutaneously. GS-6207 recently received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) as a potential therapy for heavily treatment-experienced people living with multi-drug resistant HIV. GS-6207 acts in a novel way compared with current

Pacific Drilling Appoints James W. Harris as Chief Financial Officer22.7.2019 13:42:00 CESTPress release

Pacific Drilling S.A. (NYSE: PACD), one of the world’s leading deepwater drilling contractors, today announced that Pacific Drilling’s Board has appointed James W. Harris to serve as the Company’s Senior Vice President and Chief Financial Officer. Mr. Harris replaces Mr. Johannes (John) P. Boots, who, as previously announced, mutually agreed with the Company to step down from his position to pursue other opportunities. Mr. Harris has more than 30 years of experience in the energy industry in a variety of financial leadership, strategic and business planning roles. He most recently served as Executive Vice President, Drilling & Subsea for Forum Energy Technologies, Inc., having previously served Forum as Chief Financial Officer for 12 years. Bernie Wolford, the Company’s Chief Executive Officer, stated, “We sincerely appreciate the many contributions that John has made during his nearly 10-year tenure with Pacific Drilling and we wish him all the best in his future endeavors.” “We are e